Stereotactic ablative radiotherapy for acquired resistance to EGFR therapy in metastatic non-small cell lung cancer

The advent of targeted therapy has transformed the treatment paradigm and survival of patients with metastatic non-small cell lung cancer (NSCLC) with driver mutations. The development of acquired resistances during treatment with tyrosine kinase inhibitors (TKIs) impedes a prolonged survival in man...

Descripción completa

Detalles Bibliográficos
Autores principales: Chicas-Sett, Rodolfo, Castilla Martinez, Juan, Hernández Blanquisett, Abrahan, Zafra, Juan, Pastor-Peidro, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884815/
https://www.ncbi.nlm.nih.gov/pubmed/36727053
http://dx.doi.org/10.3389/fonc.2022.1092875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884815/
https://www.ncbi.nlm.nih.gov/pubmed/36727053
http://dx.doi.org/10.3389/fonc.2022.1092875

Ejemplares similares